Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics

By Tarr Philip E   Rotger Margalida   Telenti Amalio  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 587-594

Future Medicine

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen   Morelló Judit   Garcia-Gascó Pilar   Rodríguez-Novoa Sonia   Soriano Vincent  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Treatment of dyslipidaemia in HIV-infected persons

By Manuel Oriol   Thiébaut Rodolphe   Darioli Roger   Tarr Philip E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1619-1645

Informa Healthcare

Access to resources Recommend Favorite

Fertility treatment options for HIV-infected individuals

By Sullivan-Pyke Chantae S   Nurudeen Sahadat K   Grossman Lisa C   Sauer Mark V   Douglas Nataki C  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1219-1231

Future Medicine

Access to resources Recommend Favorite

Despite limitations, therapeutic drug monitoring may be of value in antiretroviral treatment in HIV-infected patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite